1. Home
  2. TGTX

TGTX

TG Therapeutics Inc.

as 07-09-2025 11:37am EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Founded: 1993 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: N/A IPO Year: 1995
Target Price: $40.80 AVG Volume (30 days): 1.7M
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.24 EPS Growth: -15.69
52 Week Low/High: $16.65 - $46.48 Next Earning Date: 08-05-2025
Revenue: $386,386,000 Revenue Growth: 33.54%
Revenue Growth (this year): 84.81% Revenue Growth (next year): 38.34%

TGTX Daily Stock ML Predictions

Stock Insider Trading Activity of TG Therapeutics Inc. (TGTX)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Echelard Yann TGTX Director Jun 12 '25 Sell $36.94 10,000 $369,400.00 228,816

Share on Social Networks: